These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2586785)

  • 1. Phenytoin suspension.
    Rankine DA; Sadler RM
    Neurology; 1989 Dec; 39(12):1644. PubMed ID: 2586785
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of alkaline phosphatase to correct the underestimation of fosphenytoin concentration in serum measured by phenytoin immunoassays.
    Dasgupta A; Warner BF; Datta P
    Am J Clin Pathol; 1999 Apr; 111(4):557-62. PubMed ID: 10191778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarization immunoassay of phenytoin employing a sulfonamido derivative of 2-naphthol-8-sulfonic acid as a label.
    O'Neal JS; Schulman SG
    Anal Chem; 1984 Dec; 56(14):2888-91. PubMed ID: 6395717
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of storage and shaking on the settling properties of phenytoin suspension.
    Sarkar MA; Garnett WR; Karnes HT
    Neurology; 1989 Feb; 39(2 Pt 1):207-9. PubMed ID: 2915790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM; Islam SI
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of phenytoin sodium suspensions for the treatment of open wounds.
    Rhodes RS; Kuykendall JR; Heyneman CA; May MP; Bhushan A
    Int J Pharm Compd; 2006; 10():74-8. PubMed ID: 23974120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 8. Recovery of phenytoin suspension after in vitro administration through percutaneous endoscopic gastrostomy Pezzer catheters.
    Splinter MY; Seifert CF; Bradberry JC; Allen LV; Tu YH; Welsh JD
    Am J Hosp Pharm; 1990 Feb; 47(2):373-7. PubMed ID: 2309729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of nasogastric administration methods for phenytoin.
    Cacek AT; DeVito JM; Koonce JR
    Am J Hosp Pharm; 1986 Mar; 43(3):689-92. PubMed ID: 3706323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma.
    Jolley ME
    J Anal Toxicol; 1981; 5(5):236-40. PubMed ID: 7321548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
    Dasgupta A; Handy BC; Datta P
    Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations.
    Baumgartner R; Eitzlmayr A; Matsko N; Tetyczka C; Khinast J; Roblegg E
    Int J Pharm; 2014 Dec; 477(1-2):1-11. PubMed ID: 25304093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of phenytoin from an enteral nutrient formula.
    Hooks MA; Longe RL; Taylor AT; Francisco GE
    Am J Hosp Pharm; 1986 Mar; 43(3):685-8. PubMed ID: 3085485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of serum phenytoin concentrations in uremia is assay-dependent.
    Sirgo MA; Green PJ; Rocci ML; Vlasses PH
    Neurology; 1984 Sep; 34(9):1250-1. PubMed ID: 6540413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative determination of phenytoin in plasma by fluorescence polarization immunoassay and high performance liquid chromatography.
    Othman S; al-Turk WA; Awidi AS; Daradkeh TK; Shaheen O
    Drug Des Deliv; 1987 Sep; 2(1):41-7. PubMed ID: 3334544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin absorption from tube feedings.
    Maynard GA; Jones KM; Guidry JR
    Arch Intern Med; 1987 Oct; 147(10):1821. PubMed ID: 3116961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
    Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.